Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,788,158 papers from all fields of science
Search
Sign In
Create Free Account
Histamine H2 Receptor Antagonists [MoA]
Known as:
Histamine H2 Antagonists
, Histamine H2 Receptor Antagonists
, H2 Receptor Blockers
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
12 relations
Cimetidine
Cimetidine Hydrochloride
Famotidine
Famotidine 10 MG Oral Tablet
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Reply: Is Histamine H2 Receptor a Real Promising Target for Prevention or Treatment of Heart Failure?
P. Leary
,
M. Bristow
Journal of the American College of Cardiology
2016
Corpus ID: 27251657
2014
2014
Comparison of teprenone and famotidine against gastroduodenal mucosal damage in patients taking low‐dose aspirin
T. Takeuchi
,
K. Ota
,
+8 authors
K. Higuchi
Journal of Gastroenterology and Hepatology
2014
Corpus ID: 38293716
Proton‐pump inhibitors are known to be effective in the treatment and prevention of ulcers related to low‐dose aspirin (LDA), but…
Expand
2014
2014
Evaluation of electrolyte repletion in hematopoietic cell transplant patients receiving H-2 receptor antagonists or proton pump inhibitors
K. Smith
,
M. Gatesman
,
Spencer E. Harpe
,
W. Clark
Bone Marrow Transplantation
2014
Corpus ID: 801529
Evaluation of electrolyte repletion in hematopoietic cell transplant patients receiving H-2 receptor antagonists or proton pump…
Expand
2011
2011
An evaluation of the possible interaction of gastric acid suppressive medication and the EGFR tyrosine kinase inhibitor erlotinib.
J. Hilton
,
L. Seymour
,
A. le Maître
,
D. Tu
,
F. Shepherd
,
P. Bradbury
Journal of Clinical Oncology
2011
Corpus ID: 27761666
7523 Background: NCIC CTG BR21 trial demonstrated a 2 -month overall survival (OS) benefit from erlotinib (E), when compared to…
Expand
Review
2008
Review
2008
Pitfalls in designing trials of functional dyspepsia: the ascent and demise of itopride
S. V. Zanten
2008
Corpus ID: 208282589
The publication in this issue of Gut ( see page 10.1136/gut.2007.132449 ) of the results of the clinical trial programme…
Expand
2005
2005
Comparative study of nizatidine and famotidine for maintenance therapy of erosive esophagitis
N. Hamamoto
,
T. Hashimoto
,
+10 authors
Y. Kinoshita
Journal of Gastroenterology and Hepatology
2005
Corpus ID: 42287756
Background: The therapeutic effect of combined administration of prokinetics and histamine H2 receptor antagonists (H2RA) in…
Expand
2005
2005
Burden and cost of treatment for GERD
Y. Kinoshita
,
Shuichi Sato
Journal of gastroenterology
2005
Corpus ID: 7618419
ity. Although reports concerning GERD-induced decreases in work-related productivity are limited, missing time from work is…
Expand
2004
2004
Helicobacter pylori infection prevents the occurrence of the tolerance phenomenon of histamine H2 receptor antagonists
Tomoo Fujisawa
,
K. Adachi
,
+6 authors
Yoshikazu Kinoshita
Alimentary Pharmacology and Therapeutics
2004
Corpus ID: 22767314
Background : The attenuated anti‐secretory activity of H2 receptor antagonists (H2RA) during continuous administration is…
Expand
Review
2002
Review
2002
Pharmacologic management of gastroesophageal reflux disease
P. Katz
,
Adam H. Levy
Current Gastroenterology Reports
2002
Corpus ID: 2381903
Pharmacologic management of gastroesophageal reflux disease is based on the control of gastric acid changing the character of…
Expand
Review
1996
Review
1996
Treatment of Peptic Ulcer in the Elderly
M. Lazzaroni
,
G. Porro
Drugs & Aging
1996
Corpus ID: 41638511
SummarySome problems remain unresolved in the short and long term treatment of peptic ulcer in the elderly. These mainly concern…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required